Literature DB >> 35067177

A two-subpopulation model that reflects heterogeneity of large dense core vesicles in exocytosis.

Nan Qin1, Zhixi Chen1, Renhao Xue1.   

Abstract

Exocytosis of large dense core vesicles is responsible for hormone secretion in neuroendocrine cells. The population of primed vesicles ready to release upon cell excitation demonstrates large heterogeneity. However, there are currently no models that clearly reflect such heterogeneity. Here, we develop a novel model based on single vesicle release events from amperometry recordings of PC12 cells using carbon fiber microelectrode. In this model, releasable vesicles can be grouped into two subpopulations, namely, SP1 and SP2. SP1 vesicles replenish quickly, with kinetics of ~0.0368 s-1, but likely undergo slow fusion pore expansion (amperometric signals rise at ~2.5 pA/ms), while SP2 vesicles demonstrate slow replenishment (kinetics of ~0.0048 s-1) but prefer fast dilation of fusion pore, with an amperometric signal rising rate of ~9.1 pA/ms. Phorbol ester enlarges the size of SP2 partially via activation of protein kinase C and conveys SP1 vesicles into SP2. Inhibition of Rho GTPase-dependent actin rearrangement almost completely depletes SP2. We also propose that the phorbol ester-sensitive vesicle subpopulation (SP2) is analogous to the subset of superprimed synaptic vesicles in neurons. This model provides a meticulous description of the architecture of the readily releasable vesicle pool and elucidates the heterogeneity of the vesicle priming mechanism.

Entities:  

Keywords:  Exocytosis; large dense core vesicles; membrane fusion

Mesh:

Substances:

Year:  2022        PMID: 35067177      PMCID: PMC8942488          DOI: 10.1080/15384101.2022.2026576

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  55 in total

1.  Heterogeneity of catecholamine-containing vesicles in PC12 cells.

Authors:  R H Westerink; A de Groot; H P Vijverberg
Journal:  Biochem Biophys Res Commun       Date:  2000-04-13       Impact factor: 3.575

2.  A Rho-related GTPase is involved in Ca(2+)-dependent neurotransmitter exocytosis.

Authors:  F Doussau; S Gasman; Y Humeau; F Vitiello; M Popoff; P Boquet; M F Bader; B Poulain
Journal:  J Biol Chem       Date:  2000-03-17       Impact factor: 5.157

Review 3.  Vesicle pools and short-term synaptic depression: lessons from a large synapse.

Authors:  Ralf Schneggenburger; Takeshi Sakaba; Erwin Neher
Journal:  Trends Neurosci       Date:  2002-04       Impact factor: 13.837

4.  Superpriming of synaptic vesicles after their recruitment to the readily releasable pool.

Authors:  Jae Sung Lee; Won-Kyung Ho; Erwin Neher; Suk-Ho Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-26       Impact factor: 11.205

5.  Good practices in single-cell amperometry.

Authors:  David J Machado; Mónica S Montesinos; Ricardo Borges
Journal:  Methods Mol Biol       Date:  2008

Review 6.  Unc13 Aligns SNAREs and Superprimes Synaptic Vesicles.

Authors:  Mark T Palfreyman; Erik M Jorgensen
Journal:  Neuron       Date:  2017-08-02       Impact factor: 17.173

Review 7.  Dynamically Primed Synaptic Vesicle States: Key to Understand Synaptic Short-Term Plasticity.

Authors:  Erwin Neher; Nils Brose
Journal:  Neuron       Date:  2018-12-19       Impact factor: 17.173

8.  Releasable pools and the kinetics of exocytosis in adrenal chromaffin cells.

Authors:  F T Horrigan; R J Bookman
Journal:  Neuron       Date:  1994-11       Impact factor: 17.173

9.  Temporally resolved catecholamine spikes correspond to single vesicle release from individual chromaffin cells.

Authors:  R M Wightman; J A Jankowski; R T Kennedy; K T Kawagoe; T J Schroeder; D J Leszczyszyn; J A Near; E J Diliberto; O H Viveros
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

10.  Involvement of Rho GTPases in calcium-regulated exocytosis from adrenal chromaffin cells.

Authors:  S Gasman; S Chasserot-Golaz; M R Popoff; D Aunis; M F Bader
Journal:  J Cell Sci       Date:  1999-12       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.